Cv Sciences, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQB
CV Sciences reported a 12.2% drop in net product sales for 2025 and a 'substantial doubt' about its ability to continue as a going concern, despite improved gross margins and reduced operating losses.
OQB
CV Sciences' 2024 10-K filing reveals a year of strategic acquisitions, cost management, and mixed financial performance in the competitive consumer wellness market.
OQB
CV Sciences acquired Cultured Foods, a European plant-based food manufacturer, while reporting a slight decrease in net product sales but improved gross profit in its annual 10-K filing.